Emcure Pharmaceuticals IPO: Shark Tank’s Namita Thapar likely to earn ₹127 crore from OFS
Emcure Pharmaceuticals IPO: Shark Tank’s Namita Thapar likely to earn ₹127 crore from OFS
The Emcure Pharmaceuticals IPO is set to open from July 3, 2024, and it will close on July 5, 2024. Here are some key details about the IPO:
- Issue Size: The IPO is a combination of a fresh issue of 7,936,507 shares (worth ₹800 crore) and an Offer for Sale (OFS) of 11,428,839 shares (worth ₹1,152.03 crore). The total IPO size is ₹1,952.03 crore12.
- Price Band: The price band for Emcure Pharma IPO is set at ₹960 to ₹1,008 per share.
- Minimum Lot Size: Retail investors can apply for a minimum of 14 shares, and the minimum investment required is ₹14,112.
- Listing Date: The tentative listing date for Emcure Pharma IPO is Wednesday, July 10, 2024.
- Book Running Lead Managers: The book running lead managers for the IPO are Kotak Mahindra Capital Company Limited, Axis Capital Limited, J.P. Morgan India Private Limited, and Jefferies India Private Limited.
Emcure Pharmaceuticals IPO GMP today
Emcure Pharma IPO GMP today is +290. This indicates Emcure Pharmaceuticals share price were trading at a premium of ₹290 in the grey market, according to investorgain.com.
Considering the upper end of the IPO price band and the current premium in the grey market, Emcure Pharma IPO expected listing price was indicated at ₹1,298 apiece, which is 28.77% higher than the IPO price of ₹1,008.
‘Grey market premium’ indicates investors’ readiness to pay more than the issue price.
Your post offers practical tips for identifying profitable niches or target markets when starting a business. It’s a strategic approach to making money. For more information, click here.
Ready to monetize your blog? click here and learn how to optimize your content and attract advertisers for sponsored posts and banner ads.
Your guide to earning money online is a goldmine of information. click here to start making money today with the help of your comprehensive guide.